Single founder mutation (W380G) in type II protein C deficiency in Finland

Citation
A. Levo et al., Single founder mutation (W380G) in type II protein C deficiency in Finland, THROMB HAEM, 84(3), 2000, pp. 424-428
Citations number
18
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
THROMBOSIS AND HAEMOSTASIS
ISSN journal
03406245 → ACNP
Volume
84
Issue
3
Year of publication
2000
Pages
424 - 428
Database
ISI
SICI code
0340-6245(200009)84:3<424:SFM(IT>2.0.ZU;2-3
Abstract
The present study investigated the genetic basis for type II protein C defi ciency in Finland, where this form has an unusually high incidence. We demo nstrated that! first, a single novel mutation W380G in the protein C gene ( PROC) explained 25/26 index patients, estimated to represent two thirds of all families with type II deficiency in Finland. Second, extended chromosom al conservation, i.e. a specific haplotype, around the W380G mutation was i ndicated in unrelated patients. Third, a local geographical origin for the W380G mutation was suggested by genealogical data. These results are in con trast to the heterogeneity in type II protein C deficiency elsewhere, but c losely parallel disorders of the Finnish disease heritage. The high frequen cy of the type II disease can be explained by founder effect and subsequent enrichment of a single mutation in Finland. The present study also provide d a simple means for genetic diagnosis of this disease and the genetic test can be included in the routine screenings in this population.